Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 67707-1-Ig - Provider product page
- Provider
- Proteintech Group
- Product name
- MAP3K7 antibody
- Antibody type
- Monoclonal
- Description
- MAP3K7 antibody (Cat. #67707-1-Ig) is a mouse monoclonal antibody that shows reactivity with Human, Mouse, Rat and has been validated for the following applications: IF, IHC, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Mouse
- Conjugate
- Unconjugated
- Isotype
- IgG
- Antibody clone number
- 1A5B2
- Vial size
- 20ul, 150ul
Submitted references Kongensin a attenuates intervertebral disc degeneration by inhibiting TAK1-mediated PANoptosis of nucleus pulposus cells.
Liensinine reduces acute lung injury brought on by lipopolysaccharide by inhibiting the activation of the NF-κB signaling pathway through modification of the Src/TRAF6/TAK1 axis.
TRIM44 aggravates cardiac fibrosis after myocardial infarction via TAK1 stabilization.
IL-17 promotes melanoma through TRAF2 as a scaffold protein recruiting PIAS2 and ELAVL1 to induce EPHA5.
USP4 promotes the proliferation, migration, and invasion of esophageal squamous cell carcinoma by targeting TAK1.
Exogenous TIPE2 Inhibit TAK1 to Improve Inflammation and Neuropathic Pain Induced by Sciatic Nerve Injury Through Inactivating NF-κB and JNK.
Chen Y, Hu B, Ni F, Han Y, Shu S, Xiong L, Shao Z, Wei Y
International immunopharmacology 2024 Mar 10;129:111661
International immunopharmacology 2024 Mar 10;129:111661
Liensinine reduces acute lung injury brought on by lipopolysaccharide by inhibiting the activation of the NF-κB signaling pathway through modification of the Src/TRAF6/TAK1 axis.
Chen H, Liu F, Dai D, Ming Y, Xu Y, Huang Z, Zhang L, Sun Y
Inflammopharmacology 2024 Apr;32(2):1475-1488
Inflammopharmacology 2024 Apr;32(2):1475-1488
TRIM44 aggravates cardiac fibrosis after myocardial infarction via TAK1 stabilization.
Qian H, Lu Z, Hao C, Zhao Y, Bo X, Hu Y, Zhang Y, Yao Y, Ma G, Chen L
Cellular signalling 2023 Sep;109:110744
Cellular signalling 2023 Sep;109:110744
IL-17 promotes melanoma through TRAF2 as a scaffold protein recruiting PIAS2 and ELAVL1 to induce EPHA5.
Du J, Du Y, Chen L, Liu H
Biochimica et biophysica acta. Molecular cell research 2023 Oct;1870(7):119547
Biochimica et biophysica acta. Molecular cell research 2023 Oct;1870(7):119547
USP4 promotes the proliferation, migration, and invasion of esophageal squamous cell carcinoma by targeting TAK1.
Zhang H, Han Y, Xiao W, Gao Y, Sui Z, Ren P, Meng F, Tang P, Yu Z
Cell death & disease 2023 Nov 10;14(11):730
Cell death & disease 2023 Nov 10;14(11):730
Exogenous TIPE2 Inhibit TAK1 to Improve Inflammation and Neuropathic Pain Induced by Sciatic Nerve Injury Through Inactivating NF-κB and JNK.
Sun X, Li X, Zhou Y, Wang Y, Liu X
Neurochemical research 2022 Oct;47(10):3167-3177
Neurochemical research 2022 Oct;47(10):3167-3177
No comments: Submit comment
No validations: Submit validation data